← Back to Dashboard

KSHV

Human gammaherpesvirus 8

4
Approved Drugs
0
Phase 3
3
Phase 2
14
Preclinical
21
Total Compounds

Antiviral Compounds

AmilorideKSHVEpithelial sodium channel inhibitor
Preclinical
Human ion channel
BrincidofovirKSHVViral DNA polymerase inhibitor
Preclinical
Viral DNA pol
CamptothecinKSHVTopoisomerase I inhibitor
Preclinical
Human topoisomerase
ChloroquineKSHVAntimalaria agent; chemo/radio sensitizer
Preclinical
Human (multiple)
CidofovirKSHVViral DNA polymerase inhibitor
Preclinical
Viral DNA pol
DocosanolKSHVInhibition of fusion
Phase 2
Viral glycoprotein
FamciclovirKSHVViral DNA Polymerase Inhibitor
Approved (other)
JapanRussia
Viral DNA pol
FiacitabineKSHVInhibits viral DNA synthesis
Preclinical
Viral DNA pol
FilociclovirKSHVDual DNA polymerase/kinase inhibitor; Nucleoside analog
Preclinical
Viral DNA pol
FoscarnetKSHVPyrophosphate analog DNA polymerase inhibitor
Approved (other)
Japan
Viral DNA pol
GlycyrrhizinKSHV
Preclinical
Human TNF
Labyrinthopeptin A1KSHVInterference with viral phospholipid membrane
Preclinical
Viral membrane
Labyrinthopeptin A2KSHVviral membrane lipid phosphatidylethanolamine
Preclinical
Viral membrane
MetforminKSHVAMPK activator
Preclinical
Human PTK
MitoxantroneKSHVTopoisomerase II inhibitor
Phase 2
Human topoisomerase
NelfinavirKSHVHIV protease inhibitor
Approved (other)
Japan
Unknown
NovobiocinKSHVBacterial DNA gyrase inhibitor (targeting GyrB)
Preclinical
Unknown
SirolimusKSHVIL-2-dependent T-cell proliferation inhibitor
Phase 2
Human PTK
SorafenibKSHVB-Raf; FGFR-1; VEGFR-2 & -3; PDGFR-beta; KIT; and FLT3 inhibitor
Preclinical
Human PTK
ValganciclovirKSHVDestabilization of DNA
Approved (other)
Japan
Viral DNA pol
VerdinexorKSHVNuclear export inhibitor
Preclinical
Human exportin
Showing 1 to 21 of 21 results
Page 1 of 1